Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 17, 2006
Evaluating the effect of reducing the high-dose volume on the toxicity of radiotherapy in the treatment of bladder cancerS A Mangar, K Foo, A Norman, et al.
Journal of Biomedical Physics & Engineering|June 6, 2017
Enhancement of Toxic Substances Clearance from Blood Equvalent Solution and Human Whole Blood through High Flux Dialyzer by 1 MHz UltrasoundM B Shiran, M Barzegar Marvasti, A Shakeri-Zadeh, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|November 2, 2010
Corneal sensitivity as an ophthalmic marker of diabetic neuropathyNicola Pritchard, Katie Edwards, Dimitrios Vagenas, et al.
Diabetologia|January 20, 2012
Visual sensitivity loss in the central 30° of visual field is associated with diabetic peripheral neuropathyG P Sampson, A M Shahidi, D Vagenas, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 25, 2012
Retinal nerve fibre layer thinning associated with diabetic peripheral neuropathyA M Shahidi, G P Sampson, N Pritchard, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|March 13, 2012
Optimal image sample size for corneal nerve morphometryDimitrios Vagenas, Nicola Pritchard, Katie Edwards, et al.
Plos One|March 8, 2013
Cerebral oxygen saturation: graded response to carbon dioxide with isoxia and graded response to oxygen with isocapniaW Alan C Mutch, Sunni R Patel, Ayda M Shahidi, et al.
Acta Neuropathologica Communications|March 26, 2024
Chronic hypoxia remodels the tumor microenvironment to support glioma stem cell growthJ G Nicholson, S Cirigliano, R Singhania, et al.
Journal of Diabetes and Its Complications|July 31, 2016
A rapid decline in corneal small fibers and occurrence of foot ulceration and Charcot footCirous Dehghani, Anthony W Russell, Bruce A Perkins, et al.
Cancer Chemotherapy and Pharmacology|November 11, 2011
Phase I study of continuous afatinib (BIBW 2992) in patients with advanced non-small cell lung cancer after prior chemotherapy/erlotinib/gefitinib (LUX-Lung 4)H Murakami, T Tamura, T Takahashi, et al.
Pageof 8